GoodRx (GDRX) director Trevor Bezdek granted 73,434 RSUs and updates holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bezdek Trevor reported acquisition or exercise transactions in this Form 4 filing.
GoodRx Holdings director Trevor Bezdek reported a compensation grant of 73,434 restricted stock units (RSUs), each representing one share of Class A common stock at a stated price of $0.00 per share. These RSUs vest in full on the earlier of the one-year anniversary of June 16, 2026 or the date of the 2027 Annual Meeting of Stockholders, subject to his continued service. Following this award, he holds 343,810 Class A shares directly and has additional indirect interests through TB 2024-2 GRAT and TB 2025 GRAT. Separate JB 2024-2 GRAT and JB 2025 GRAT positions, as well as one share held by his spouse, are associated with his spouse, and he disclaims beneficial ownership of those shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Bezdek Trevor
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 73,434 | $0.00 | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 343,810 shares (Direct, null);
Class A Common Stock — 543,377 shares (Indirect, By TB 2024-2 GRAT)
Footnotes (1)
- Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. Share held directly by TB 2024 -2 GRAT, a grantor retained annuity trust (the "TB 2024-2 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. Share held directly by TB 2025 GRAT, a grantor retained annuity trust (the "TB 2025 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the TB 2025 GRAT. Share held directly by JB 2024-2 GRAT, a grantor retained annuity trust (the "JB 2024-2 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the TB 2024-2 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the TB 2024-2 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares. Share held directly by JB 2025 GRAT, a grantor retained annuity trust (the " JB 2025 GRAT"). Jana Bezdek, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the JB 2025 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the JB 2025 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
Key Figures
RSUs granted: 73,434 units
RSU grant price: $0.00 per share
Direct holdings after grant: 343,810 shares
+4 more
7 metrics
RSUs granted
73,434 units
Restricted stock units granted with code A
RSU grant price
$0.00 per share
Stated price per share for RSU award
Direct holdings after grant
343,810 shares
Class A common stock held directly following transaction
TB 2025 GRAT holdings
2,089,343 shares
Indirect Class A holdings via TB 2025 GRAT
TB 2024-2 GRAT holdings
543,377 shares
Indirect Class A holdings via TB 2024-2 GRAT
JB 2025 GRAT holdings
2,089,343 shares
Shares held by JB 2025 GRAT; beneficial ownership disclaimed
JB 2024-2 GRAT holdings
543,377 shares
Shares held by JB 2024-2 GRAT; beneficial ownership disclaimed
Key Terms
restricted stock units, grantor retained annuity trust, pecuniary interest, beneficial ownership
4 terms
restricted stock units financial
"Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grantor retained annuity trust financial
"Share held directly by TB 2025 GRAT, a grantor retained annuity trust (the "TB 2025 GRAT")."
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
pecuniary interest financial
"The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the JB 2025 GRAT"
beneficial ownership financial
"and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What did GoodRx (GDRX) director Trevor Bezdek report in this Form 4?
Trevor Bezdek reported receiving 73,434 restricted stock units of GoodRx Class A common stock as a compensation award. The filing also updates his direct and indirect holdings, including 343,810 shares held directly after the grant.
How do the GoodRx (GDRX) RSUs granted to Trevor Bezdek vest?
The 73,434 restricted stock units vest in full on the earlier of the one-year anniversary of June 16, 2026 or the date of the 2027 Annual Meeting of Stockholders, subject to his continued service with the company through the applicable vesting date.
What indirect GoodRx (GDRX) holdings are associated with Trevor Bezdek’s TB GRATs?
Indirect holdings include 2,089,343 shares in TB 2025 GRAT and 543,377 shares in TB 2024-2 GRAT. Bezdek serves as sole trustee and annuitant of these grantor retained annuity trusts, which are reported as indirect ownership interests.
Are the new GoodRx (GDRX) RSUs an open-market purchase by Trevor Bezdek?
No. The 73,434 restricted stock units are a grant, award, or other acquisition recorded with transaction code A. They represent equity compensation, not an open-market stock purchase by the director.